Beta-blockers should be saved in the first-line therapy of hypertension

1. Закат эры блокаторов В-адренорецепторов? Пресс-служба «Еженедельника аптека» 2006г.

2.

3. Lindholm L.H., Carlberg В., Samuelsson О. Shoud B-blockers first chouse in the treatment of primary hypertension? A meta-analisys. Lancet 2005; 366:1545-53.

4.

5. Bradley H.A., Wiysonge C.S., Volmink J.A. et al. How strong is the evidence for use of beta-blockers as first-line therapy for hypertension? Systematic review and meta-analysis. J of Hypertension 2006;24:2131-2141.

6.

7. Dahlof B., Hansson L., Schersten В. et al. Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension). Lancet 1991;338:1281-1285.

8.

9. Hansson L., Lindholm L.H., Ekbom T. et al. Randomised trial of old and new antihypertensive drugs in elderly patients: cardiovascular mortality and morbidity in Swedish Trial in OLD Patients with Hypertension-2 study. Lancet 1999;354:1751-6.

10.

11. Wikstrand J., Warnold I., Olsson G. et al. Primary prevention with metoprolol in patients with hypertension. Mortality results grom the MAPHY study. JAMA 1988 Apr 1;259 (13):1976-82.

12.

13. Wikstrand J., Warnold I., Tuomilehto J. et al. Metoprolol versus thiazide diuretics in hypertension. Morbidity results from the MAPHY study. Hypertension, 1991;17;579-588.

14.

15. Wilhelmsen L., Berglund G., Elmfeldt D. et al. Beta-Blockers Versus Diuretics in Hypertensive Men: Main Results from the HAPPHY Trial. Journal of Hypertension 1987;5:561-572

16.

17. Конради А.О. Бета-блокаторы в лечении артериальной гипертензии - наступило ли время забвения? Артериальная гипертензия, 2006, №3, с.212-215.

18.

19. Djian J Clinical evaluation of betaxolol as a once-daily treatment for hypertension in 4685 petients. Br J Clm Pract 1985;39:188-191.

20.

21. Бытрова М.М., Бритов А.Н., Горбунов Ю.М. и соавт. Лечение артериальной гипертензии у женщин в мнопаузе. Терап.архив. 1999;71(6):67-69.

22.

23. Messerly F.H., Grossman E. Therapeutic Controversies in Hypertension. 2005; Semin Nephrol 25:227-235.

24.

25. GEMINI study. Metabolic effect of carvedilol vs metoprolol in patients with type 2 diabetes mellitus and hypertension: a rondomized controlled trial. JAMA 292:2227-2236,2004.

26.

27. Маколкин В.И. Возможно ли применение β-адреноблокаторов при артериальной гипертонии у больных метаболическим синдромом и сахарным диабетом 2 типа? Русский медицинский журнал. 2005;13(11):3-6.

28.

29. Чазова И.Е., Мычка В.Б. Метаболический синдром. Media Medica. 2004, с. 164.

30.

31. Kaiser Т., Heise Т., Nosek L. et al. Influence of nebivolol and enalapril on metabolic parameters and arterial stiffness in hypertensive type 2 diabetic patients. J Hypertens 2006; 24 (7): 1397-1403.

32.

33. Boydak В., Nalbantgil S., Fici F. et al. A randomized comparison of the effects of nebivolol and atenolol with and without chlorthalidone on the sexual function of hypertensive men. Clin Drug Invest 2005; 25(6): 409-415.

34.

35. Cazzola M., Matera M.G., Ruggeri P. et al. Comparative effects of a two-week treatment with nebivolol and nifedipine in hypertensive patients suffering from COPD // Respiration. - 2004. -Issue 2. - Vol. 71. - P. 159-164.

36.

37. Matthys H., Giebelhaus V., von Fallois J. Nebivolol (nebilet) a beta blocker of the third generation-also for patients with obstructive lung diseases? // Zeitschrift fur Kardiologie. -2001. - Issue 10. - Vol. 90. - P. 760-765.

38.

39. Zuber M., Erne P. Changes in Peak Respiratory Flow and Quality of Life during Nebivolol Therapy // Heart Drag. - 2004. -4.-P. 103-108.

40.